Your session is about to expire
← Back to Search
PTLD - active taVNS for Lyme Disease
Study Summary
This trial seeks to assess a new, non-antibiotic approach to treat symptoms of Lyme disease after antibiotic treatment. taVNS offers potential to reduce burden of symptoms without side effects.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could I potentially qualify for participation in this experiment?
"To be eligible for the trial, potential participants must have lyme disease syndrome post-treatment and lie within a certain age range (18-65). A total of 12 individuals are expected to take part."
Are there any available slots in this experiment?
"Based on the information available from clinicaltrials.gov, it is apparent that this study has concluded its recruitment of participants; after being posted in April 1st 2023 and most recently updated on March 8th 2023. Nonetheless, there are still 9 other medical trials seeking candidates at present."
Does this experiment encompass geriatric patients?
"As detailed in the inclusion criteria, individuals aged 18 to 65 are eligible for this trial. In contrast, there are four other studies that accept minors and seven different ones designed for patients over the age of sixty-five."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger